首页    期刊浏览 2024年10月06日 星期日
登录注册

文章基本信息

  • 标题:KINETIC STUDY ON DISAPPEARANCE OF γ-BUTYROLACTONE-γ-CARBONYL-L-HISTIDYL-L-PROLINAMIDE (DN-1417) FROM PLASMA USING A RADIOIMMUNOASSAY FOR DN-1417 ISOBUTYLAMIDE
  • 本地全文:下载
  • 作者:ICHIYO OSHIMA ; SHIRO SAITO ; KUNIO SHIOTA
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:1983
  • 卷号:6
  • 期号:3
  • 页码:202-208
  • DOI:10.1248/bpb1978.6.202
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:Kinetic study of disappearance of γ-butyrolactone-γ-carbonyl-L-histidy-L-prolinamide (DM-1417) from human plasma has been performed by a sensitive and specific radioimmunoassay (RIA) using antiserum against DN-1417 isobutylamide. Antibody against N-[2-hydroxy-4-(isobutylcarbamoyl)butyryl]-L-histidy-L-prolinamide (DN-isobutylamide) did not cross-react with any other TRH-related peptides tested. DN-isobutylamide was radioiodinated with 125I by the chloramine T method and the product had a specific activity of about 160μCi/μg. The sensitivity of the RIA was 50pg per tube, and the intra- and inter-assay coefficients of variation at concentrations of 1-10ng/ml were 7.0-11.6%. DN-1417 in the plasma was converted to a stable form, DN-isobutylamide, by incubation with isopropanol-isobutylamine at room temperature for 2h. DN-Isobutylamide was separated from 2-hydroxy-4-carboxybutyryl-L-histidyl-L-prolinamide (DN-COOH) using a SEP-PAKTM C18 cartridge before RIA. The recovery of DN-isobutylamide from plasma was 86.2-98.2%. The half-life, volume of distribution and plasma clearance rate of DN-1417 examined in 6 normal male volunteers by intravenous injection of 500μg DN-1417 citrate were 11.5±5.6min in the first phase and 89.5±33.5min in the second phase, 25.3±10.0 liters and 745.8±278.6 1/d, respectively. These results indicate that RIA of DN-isobutylamide is useful for analysing DN-1417 metabolism in humans.
  • 关键词:human
国家哲学社会科学文献中心版权所有